Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

NCT02214979 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Telmisartan/Ramipril
DRUG: Telmisartan
DRUG: Ramipril capsule
DRUG: Ramipril tablet

Sponsor

Boehringer Ingelheim